Related Experiment Video
Updated: Aug 15, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Uncovering Hereditary Risk: Germline Homologous Recombination Repair Variant Spectrum in a Large North Indian Cancer
Akhil Kapoor1, Srushti Uthale2, Anamika Chain2
1Medical Oncology, Mahamana Pandit Madanmohan Malaviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Homi Bhabha National Institute, Varanasi, India.
Homologous recombination repair (HRR) gene alterations are common in Indian cancer patients, with non-BRCA genes playing a significant role. Comprehensive HRR panel testing is crucial for identifying patients eligible for targeted therapies.
Area of Science:
- Genetics and Genomics
- Oncology
- Cancer Research
Background:
- Homologous recombination repair (HRR) pathway defects are key drivers of hereditary cancers.
- Limited population-specific prevalence data exists for India.
- Current testing often focuses solely on BRCA1/2, potentially missing other actionable HRR variants.
Purpose of the Study:
- To determine the prevalence of HRR gene alterations in an Indian cohort.
- To assess the contribution of non-BRCA HRR genes to hereditary cancers in India.
- To inform diagnostic and therapeutic strategies for Indian cancer patients.
Main Methods:
- Retrospective observational cohort study of 950 consecutive patients.
- Germline testing using a comprehensive next-generation sequencing HRR gene panel.
- Analysis of variants in BRCA1, BRCA2, PALB2, RAD51C, RAD51D, ATM, CHEK2, BRIP1, BARD1, RAD50, NBN, MRE11, and FANCC.
Main Results:
- 38.3% of patients had variants in HRR genes; 28% had pathogenic/likely pathogenic (P/LP) variants.
- BRCA1 (68.4%) and BRCA2 (13.9%) were the most frequent P/LP variants.
- Non-BRCA HRR genes accounted for 17.6% of P/LP variants, with PALB2 being most common (5.2%).
Conclusions:
- A high prevalence of HRR gene alterations, including non-BRCA genes, was observed in this Indian cohort.
- Comprehensive HRR gene panel testing is recommended for Indian populations.
- Findings support targeted therapies like PARP inhibitors and platinum-based treatments.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Homologous Recombination
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

